Moexipril Hydrochloride Tablet, Film Coated
Product Images NDC 0093-0017

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moexipril Hydrochloride (NDC 0093-0017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Moexipril Hydrochloride, a film-coated tablet and human prescription drug by Teva Pharmaceuticals USA, Inc. The structure includes methoxy groups, a carboxyl group, and an ethyl ester bound to a bicyclic ring system with hydrochloride salt indicated.*

FDA Label Image

Image 2

Label for Moexipril Hydrochloride Tablets USP 7.5 mg film-coated tablets by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 100 tablets and includes storage instructions and safety warnings. The NDC code 0093-0017-01 is shown, along with a barcode and manufacturer details.*

FDA Label Image

Image 3

Label for Moexipril Hydrochloride Tablets USP 15 mg, oral film-coated tablets. The label indicates a package size of 100 tablets and the product is labeled by Teva Pharmaceuticals USA, Inc. The label includes an NDC number 0093-5150-01 and usage instructions stating each tablet contains 15 mg of moexipril hydrochloride USP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.